These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37464913)

  • 1. Inflammatory cytokines in maternal serum between women with threatened miscarriage and normal pregnancy.
    Hakeem LA; Bello YO; Obajimi GO; Onifade AFA; Ahmed B; Arowojolu AO; Morhason-Bello IO
    Int J Gynaecol Obstet; 2024 Jan; 164(1):255-261. PubMed ID: 37464913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defects in protective cytokine profiles in spontaneous miscarriage in the first trimester.
    Ku CW; Ong LS; Goh JP; Allen J; Low LW; Zhou J; Tan TC; Lee YH
    F S Sci; 2023 Feb; 4(1):36-46. PubMed ID: 36096448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum progesterone distribution in normal pregnancies compared to pregnancies complicated by threatened miscarriage from 5 to 13 weeks gestation: a prospective cohort study.
    Ku CW; Allen JC; Lek SM; Chia ML; Tan NS; Tan TC
    BMC Pregnancy Childbirth; 2018 Sep; 18(1):360. PubMed ID: 30185145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone - induced blocking factor (PIBF) and Th(1)/Th(2) cytokine in women with threatened spontaneous abortion.
    Hudić I; Fatusić Z
    J Perinat Med; 2009; 37(4):338-42. PubMed ID: 19290853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal cytokine levels in non-pregnant women with a history of recurrent miscarriage.
    Wilson R; Jenkins C; Miller H; McInnes IB; Moore J; McLean MA; Walker JJ
    Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115(1):51-4. PubMed ID: 15223165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obstetric outcome and cytokine levels in threatened miscarriage.
    Calleja-Agius J; Schembri-Wismayer P; Calleja N; Brincat M; Spiteri D
    Gynecol Endocrinol; 2011 Feb; 27(2):121-7. PubMed ID: 20500112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-helper 2-cytokine levels in women with threatened abortion.
    Paradisi R; Maldini-Casadei M; Boni P; Busacchi P; Porcu E; Venturoli S
    Eur J Obstet Gynecol Reprod Biol; 2003 Nov; 111(1):43-9. PubMed ID: 14557010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro- and Anti-Inflammatory Cytokines in the First Trimester-Comparison of Missed Miscarriage and Normal Pregnancy.
    Kwiatek M; Gęca T; Kwaśniewska A
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of oral progestogen in women with threatened miscarriage in the first trimester: a randomized double-blind controlled trial.
    Chan DMK; Cheung KW; Ko JKY; Yung SSF; Lai SF; Lam MT; Ng DYT; Lee VCY; Li RHW; Ng EHY
    Hum Reprod; 2021 Feb; 36(3):587-595. PubMed ID: 33331637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Threatened miscarriage as a predictor of obstetric outcome.
    Johns J; Jauniaux E
    Obstet Gynecol; 2006 Apr; 107(4):845-50. PubMed ID: 16582121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of serum biomarkers in the prediction of outcome in women with threatened miscarriage: a systematic review and diagnostic accuracy meta-analysis.
    Pillai RN; Konje JC; Tincello DG; Potdar N
    Hum Reprod Update; 2016; 22(2):228-39. PubMed ID: 26663220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The costimulatory signal upregulation is associated with Th1 bias at the maternal-fetal interface in human miscarriage.
    Jin LP; Fan DX; Zhang T; Guo PF; Li DJ
    Am J Reprod Immunol; 2011 Oct; 66(4):270-8. PubMed ID: 21481059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal plasma cytokines in early- and mid-gestation of normal human pregnancy and their association with maternal factors.
    Curry AE; Vogel I; Skogstrand K; Drews C; Schendel DE; Flanders WD; Hougaard DM; Thorsen P
    J Reprod Immunol; 2008 Apr; 77(2):152-60. PubMed ID: 17692390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal first trimester serum interleukin 18 levels are associated with a poor outcome in women with a history of recurrent miscarriage.
    Wilson R; Moor J; Jenkins C; Miller H; Walker JJ; McLean MA; Norman J; McInnes IB
    Am J Reprod Immunol; 2004 Feb; 51(2):156-9. PubMed ID: 14748843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone-induced blocking factor and cytokine profile in women with threatened pre-term delivery.
    Hudić I; Fatusić Z; Szekeres-Bartho J; Balić D; Polgar B; Ljuca D; Dizdarević-Hudić L
    Am J Reprod Immunol; 2009 May; 61(5):330-7. PubMed ID: 19343831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bioplex analysis of cytokines and chemokines in first trimester maternal plasma to screen for predictors of miscarriage.
    Hannan NJ; Bambang K; Kaitu'u-Lino TJ; Konje JC; Tong S
    PLoS One; 2014; 9(4):e93320. PubMed ID: 24699265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between threatened miscarriage and gestational diabetes mellitus.
    Lee HJ; Norwitz E; Lee B
    BMC Pregnancy Childbirth; 2018 Aug; 18(1):318. PubMed ID: 30081861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of a T(H) 1 type response associated with recurrent miscarriage.
    Jenkins C; Roberts J; Wilson R; MacLean MA; Shilito J; Walker JJ
    Fertil Steril; 2000 Jun; 73(6):1206-8. PubMed ID: 10856484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal serum levels of pro-inflammatory cytokines in missed and threatened abortion.
    Paradisi R; Porcu E; Venturoli S; Maldini-Casadei M; Boni P
    Am J Reprod Immunol; 2003 Oct; 50(4):302-8. PubMed ID: 14672332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obstetric outcome after threatened miscarriage with and without a hematoma on ultrasound.
    Johns J; Hyett J; Jauniaux E
    Obstet Gynecol; 2003 Sep; 102(3):483-7. PubMed ID: 12962928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.